Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey

被引:41
作者
Cherutich, Peter [1 ]
Kim, Andrea A. [2 ]
Kellogg, Timothy A. [3 ]
Sherr, Kenneth [4 ]
Waruru, Anthony [2 ]
De Cock, Kevin M. [2 ]
Rutherford, George W. [3 ]
机构
[1] Minist Hlth, Natl AIDS STI Control Programme, Nairobi, Kenya
[2] US Ctr Dis Control & Prevent, Div Global HIV & TB, Nairobi, Kenya
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Washington, Seattle, WA 98195 USA
关键词
CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; PREVENTION; CARE; TRANSMISSION; PREDICTORS; ENGAGEMENT; INFECTION; ADHERENCE; SPECTRUM;
D O I
10.1371/journal.pone.0154318
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction At the individual level, there is clear evidence that Human Immunodeficiency Virus (HIV) transmission can be substantially reduced by lowering viral load. However there are few data describing population-level HIV viremia especially in high-burden settings with substantial under-diagnosis of HIV infection. The 2nd Kenya AIDS Indicator Survey (KAIS 2012) provided a unique opportunity to evaluate the impact of antiretroviral therapy (ART) coverage on viremia and to examine the risks for failure to suppress viral replication. We report population-level HIV viral load suppression using data from KAIS 2012. Methods Between October 2012 to February 2013, KAIS 2012 surveyed household members, administered questionnaires and drew serum samples to test for HIV and, for those found to be infected with HIV, plasma viral load (PVL) was measured. Our principal outcome was unsuppressed HIV viremia, defined as a PVL >= 550 copies/mL. The exposure variables included current treatment with ART, prior history of an HIV diagnosis, and engagement in HIV care. All point estimates were adjusted to account for the KAIS 2012 cluster sampling design and survey non-response. Results Overall, 61.2% (95% CI: 56.4-66.1) of HIV-infected Kenyans aged 15-64 years had not achieved virological suppression. The base(10) median (interquartile range [IQR]) and mean (95% CI) VL was 4,633 copies/mL (0-51,596) and 81,750 copies/mL (59,366-104,134), respectively. Among 266 persons taking ART, 26.1% (95% CI: 20.0-32.1) had detectable viremia. Non-ART use, younger age, and lack of awareness of HIV status were independently associated with significantly higher odds of detectable viral load. In multivariate analysis for the sub-sample of patients on ART, detectable viremia was independently associated with younger age and sub-optimal adherence to ART. Discussion This report adds to the limited data of nationally-representative surveys to report population-level virological suppression. We established heterogeneity across the ten administrative and HIV programmatic regions on levels of detectable viral load. Timely initiation of ART and retention in care are crucial for the elimination of transmission of HIV through sex, needle and syringe use or from mother to child. Further refinement of geospatial mapping of populations with highest risk of transmission is necessary.
引用
收藏
页数:14
相关论文
共 32 条
[1]   Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study [J].
Anderson, Sarah-Jane ;
Cherutich, Peter ;
Kilonzo, Nduku ;
Cremin, Ide ;
Fecht, Daniela ;
Kimanga, Davies ;
Harper, Malayah ;
Masha, Ruth Laibon ;
Ngongo, Prince Bahati ;
Maina, William ;
Dybul, Mark ;
Hallett, Timothy B. .
LANCET, 2014, 384 (9939) :249-256
[2]  
[Anonymous], B WHO
[3]  
[Anonymous], 2014, An ambitious treatment target to help end AIDS Epidemic
[4]  
[Anonymous], 2015, FAST TRACK END AIDS
[5]  
[Anonymous], C RETR OPP INF ATL G
[6]   Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis [J].
Attia, Suzanna ;
Egger, Matthias ;
Mueller, Monika ;
Zwahlen, Marcel ;
Low, Nicola .
AIDS, 2009, 23 (11) :1397-1404
[7]   Lack of Knowledge of HIV Status a Major Barrier to HIV Prevention, Care and Treatment Efforts in Kenya: Results from a Nationally Representative Study [J].
Cherutich, Peter ;
Kaiser, Reinhard ;
Galbraith, Jennifer ;
Williamson, John ;
Shiraishi, Ray W. ;
Ngare, Carol ;
Mermin, Jonathan ;
Marum, Elizabeth ;
Bunnell, Rebecca .
PLOS ONE, 2012, 7 (05)
[8]   Prevention of HIV-1 Infection with Early Antiretroviral Therapy [J].
Cohen, Myron S. ;
Chen, Ying Q. ;
McCauley, Marybeth ;
Gamble, Theresa ;
Hosseinipour, Mina C. ;
Kumarasamy, Nagalingeswaran ;
Hakim, James G. ;
Kumwenda, Johnstone ;
Grinsztejn, Beatriz ;
Pilotto, Jose H. S. ;
Godbole, Sheela V. ;
Mehendale, Sanjay ;
Chariyalertsak, Suwat ;
Santos, Breno R. ;
Mayer, Kenneth H. ;
Hoffman, Irving F. ;
Eshleman, Susan H. ;
Piwowar-Manning, Estelle ;
Wang, Lei ;
Makhema, Joseph ;
Mills, Lisa A. ;
de Bruyn, Guy ;
Sanne, Ian ;
Eron, Joseph ;
Gallant, Joel ;
Havlir, Diane ;
Swindells, Susan ;
Ribaudo, Heather ;
Elharrar, Vanessa ;
Burns, David ;
Taha, Taha E. ;
Nielsen-Saines, Karin ;
Celentano, David ;
Essex, Max ;
Fleming, Thomas R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06) :493-505
[9]  
Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618
[10]   Plus ca change ... Antiretroviral Therapy, HIV Prevention, and the HIV Treatment Cascade [J].
De Cock, Kevin M. .
CLINICAL INFECTIOUS DISEASES, 2014, 58 (07) :1012-1014